GEO Group Q3 2026: Record EBITDA, EPS Beat, and a $1.25B Buyback
As seen on the 24/7 Wall St. homepage on November 5, 2026.
New and expanded ICE contracts worth roughly $500 million in incremental annual revenue carried the quarter, lifting adjusted EBITDA 21% even as the top line missed expectations. Management raised full-year adjusted EPS guidance and boosted the buyback program, calling the stock significantly undervalued.
Continue ReadingShow less
GEO Group's third quarter of 2026 was the strongest in the company's history by two key measures. Revenue climbed 11.5% year over year to $761.1 million and adjusted EBITDA rose 21% to $145.3 million, both company records. Adjusted EPS of $0.39 cleared the consensus estimate of $0.345 by about 13%, continuing a streak of beats that stretches back to Q2 2025.
The engine behind that profit growth was a surge in ICE detention contracts. Management cited roughly $500 million in incremental annual revenue from new or expanded agreements signed in 2026 alone. Flagship deals include a 10-year intergovernmental agreement for the 2,329-bed Big Spring Complex in Texas, expected to generate about $200 million in annual revenues, as well as a new 10-year contract for the 1,635-bed Northwest ICE Processing Center in Tacoma worth about $140 million annually.
Revenue did miss Wall Street's $772.7 million estimate by about 1.5%, a gap the market will weigh against the profit outperformance. Several newly activated facilities are still ramping toward normalized operations, with Big Horn and Rivers expected to stabilize in early 2027 and Big Spring in Q2 2027, so the full revenue contribution from the current contract pipeline has not yet arrived in the results.
Sponsored
On the capital allocation front, the board expanded the share repurchase authorization from $500 million to $1.25 billion. As of November 5, 2026, roughly 10.1 million shares had been bought back for approximately $177 million, leaving about $1.07 billion available. CEO George C. Zoley described the stock as "significantly undervalued" given the company's 48,000 owned beds and called buybacks "a paramount capital allocation priority."
Management raised full-year 2026 adjusted EPS guidance to $1.40 to $1.44, with revenues now expected in a range of $2.975 billion to $3.025 billion and adjusted EBITDA of $568 million to $573 million. Separately, the completed $950 million sale of the Adelanto Complex to DHS will contribute a large one-time gain to GAAP net income, though guidance for the ongoing business strips that out. The outlook excludes any potential one-time legal settlements, and risks flagged by the company include changes in federal immigration policy, labor cost inflation, and the outcome of the Nwauzor litigation currently before the U.S. Supreme Court.
Mentioned: GEO